https://medlineplus.gov/druginfo/meds/a624074.html
Atezolizumab and hyaluronidase-tqjs Injection: MedlinePlus Drug Information
Atezolizumab and hyaluronidase-tqjs Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus
atezolizumabhyaluronidaseinjectionmedlineplusdrug
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lurbinectedin-combination-atezolizumab-or-atezolizumab-and-hyaluronidase-tqjs-extensive
FDA approves lurbinectedin in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs...
On October 2, 2025, the Food and Drug Administration approved lurbinectedin (Zepzelca, Jazz Pharmaceuticals, Inc.) in combination with atezolizumab (Tecentriq,...
fda approveslurbinectedincombination
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-atezolizumab-and-hyaluronidase-tqjs-subcutaneous-injection
FDA approves atezolizumab and hyaluronidase-tqjs for subcutaneous injection | FDA
On September 12, 2024, the Food and Drug Administration approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc.) for subcutaneous...
fda approvesatezolizumabhyaluronidasesubcutaneousinjection